NCT00672256

Brief Summary

The broad objective of this proposal is to identify functional neuroanatomical correlates of impairments in response inhibition during smoking abstinence. We will measure changes in performance and regional blood oxygenation levels using functional magnetic resonance imaging (fMRI)while smokers complete tasks designed to assess decision making and response inhibition. Our primary hypothesis is that smoking abstinence will result in impaired response inhibition accompanied by decreases in blood-oxygenation-level-dependent (BOLD) fMRI signal in brain regions associated with these cognitive processes including frontal cortex and the ventral striatum. Abstinence may also result in performance-related increases in activation in brain regions associated with effortful processing including the anterior cingulate cortex in effort to compensate for deficits in other regions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

May 4, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 6, 2008

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
4 years until next milestone

Results Posted

Study results publicly available

February 15, 2013

Completed
Last Updated

July 23, 2014

Status Verified

March 1, 2013

Enrollment Period

2.2 years

First QC Date

May 4, 2008

Results QC Date

March 30, 2009

Last Update Submit

July 14, 2014

Conditions

Keywords

SmokingfMRI

Outcome Measures

Primary Outcomes (4)

  • Signal Change in Functional Magnetic Resonance Imaging (fMRI) BOLD Signal Between Response Inhibition Trials and Control Trials in Right Inferior Frontal Cortex (rIFC) During Task on Satiated Day

    Percent signal change in fMRI BOLD response in rIFC to correctly inhibited targets (as compared to control trials) during a response inhibition task following smoking as usual. Response inhibition trials are trials in the task in which the participant must inhibit a response (not press the button)when presented with a No-Go trial. Control trials are trials in the task in which the participant must press the button when presented with a Go trial.

    12.5 minutes of fMRI scanning following smoking as usual

  • Signal Change in fMRI BOLD Signal Between Response Inhibition Trials and Control Trials in Right Inferior Frontal Cortex (rIFC) During Task on Abstinent Day

    Percent signal change in fMRI BOLD response in rIFC to correctly inhibited targets (as compared to control trials) during a response inhibition task following not smoking for 24 hours. Response inhibition trials are trials in the task in which the participant must inhibit a response (not press the button)when presented with a No-Go trial. Control trials are trials in the task in which the participant must press the button when presented with a Go trial.

    12.5 minutes of fMRI scanning following 24 hrs smoking abstinence

  • Signal Change in fMRI BOLD Signal Between Response Inhibition Trials and Control Trials in Presupplementary Motor Area (Pre-SMA) During Task on Abstinent Day

    Percent signal change in fMRI BOLD response in pre-SMA to correctly inhibited targets (as compared to control trials) during a response inhibition task following not smoking for 24 hours. Response inhibition trials are trials in the task in which the participant must inhibit a response (not press the button)when presented with a No-Go trial. Control trials are trials in the task in which the participant must press the button when presented with a Go trial.

    12.5 minutes of fMRI scanning following 24 hrs smoking abstinence

  • Signal Change in fMRI BOLD Signal Between Response Inhibition Trials and Control Trials in Presupplementary Motor Area (Pre-SMA) During Task on Satiated Day

    Percent signal change in fMRI BOLD response in pre-SMA to correctly inhibited targets (as compared to control trials) during a response inhibition task following smoking as usual. Response inhibition trials are trials in the task in which the participant must inhibit a response (not press the button)when presented with a No-Go trial. Control trials are trials in the task in which the participant must press the button when presented with a Go trial.

    12.5 minutes of fMRI scanning following smoking as usual

Study Arms (1)

Smokers not interested in quitting smoking

EXPERIMENTAL

Smokers were scanned 24 hours after quitting smoking, and scanned after smoking as usual.

Behavioral: Smoking Abstinence

Interventions

Smokers were scanned after having quitting smoking for 24 hours, and scanned after smoking as usual.

Smokers not interested in quitting smoking

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Smoker subjects must have
  • smoked an average of 10 cigarettes per day for two continuous years of a brand that delivers (by Federal Trade Commission rated yields) at least 0.5 mg nicotine
  • have an expired air carbon monoxide reading of at least 10 ppm.
  • must be in general good health
  • Non-smoker subjects must have
  • smoked less than 50 cigarettes in their lifetime
  • have not smoked in the last six months
  • have an expired air carbon monoxide reading of less than or equal to 5 ppm.
  • must be in general good health.

You may not qualify if:

  • major medical condition
  • anything that would make participation unsafe (e.g., have pacemaker or other metallic implant) or uncomfortable (e.g., chronic pain)
  • psychiatric condition
  • suffering from claustrophobia
  • current alcohol or drug abuse
  • smokeless tobacco use, or use of nicotine replacement therapy or other smoking cessation treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Medical Center

Durham, North Carolina, 27705, United States

Location

Related Links

MeSH Terms

Conditions

Smoking

Condition Hierarchy (Ancestors)

Behavior

Results Point of Contact

Title
Joseph McClernon
Organization
Duke University Medical Center

Study Officials

  • Francis J McClernon, Ph.D

    Duke University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2008

First Posted

May 6, 2008

Study Start

January 1, 2007

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

July 23, 2014

Results First Posted

February 15, 2013

Record last verified: 2013-03

Locations